A review on the epidemiology of rheumatoid arthritis: An update and trends from current literature

IF 4.8 2区医学 Q1 RHEUMATOLOGY Best Practice & Research in Clinical Rheumatology Pub Date : 2025-03-01 Epub Date: 2025-02-11 DOI:10.1016/j.berh.2025.102036

Perpetual Uke , Ajesh Maharaj , Adewale Adebajo

{"title":"A review on the epidemiology of rheumatoid arthritis: An update and trends from current literature","authors":"Perpetual Uke , Ajesh Maharaj , Adewale Adebajo","doi":"10.1016/j.berh.2025.102036","DOIUrl":null,"url":null,"abstract":"<div><div>Rheumatoid arthritis (RA) is a systemic, chronic autoimmune disease affecting mainly the joints, often with extra articular manifestations. This review provides an update on RA epidemiological trends and management.</div><div>PubMed and EMBASE were searched from 2014 to 2024 using rheumatoid arthritis as keyword, combined with incidence, prevalence, diagnosis, classification, and management. Emphasis was on papers published in the past 5 years.</div><div>Globally, the age-standardised prevalence and incidence rate (ASPR and ASIR) of RA increased with varying figures. The ASPR increased by 0.37%, 14.1%, and 6.4% from 1990 to 2019, 2020 and 2017 respectively; and 9% from 1980 to 2019. The ASIR increased by 0.3% and 8.2% from 1990 to 2019 and 2017 respectively; the disability-adjusted life years (DALY) figures increased 0.12% and decreased 0.36% in the same period from different authors. Reduction in ASIR were reported while ASPR varies. Disease modifying anti-rheumatic drugs (DMARDs) remain the cornerstone of treatment.</div></div>","PeriodicalId":50983,"journal":{"name":"Best Practice & Research in Clinical Rheumatology","volume":"39 1","pages":"Article 102036"},"PeriodicalIF":4.8000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Best Practice & Research in Clinical Rheumatology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S152169422500004X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/11 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Rheumatoid arthritis (RA) is a systemic, chronic autoimmune disease affecting mainly the joints, often with extra articular manifestations. This review provides an update on RA epidemiological trends and management.

PubMed and EMBASE were searched from 2014 to 2024 using rheumatoid arthritis as keyword, combined with incidence, prevalence, diagnosis, classification, and management. Emphasis was on papers published in the past 5 years.

Globally, the age-standardised prevalence and incidence rate (ASPR and ASIR) of RA increased with varying figures. The ASPR increased by 0.37%, 14.1%, and 6.4% from 1990 to 2019, 2020 and 2017 respectively; and 9% from 1980 to 2019. The ASIR increased by 0.3% and 8.2% from 1990 to 2019 and 2017 respectively; the disability-adjusted life years (DALY) figures increased 0.12% and decreased 0.36% in the same period from different authors. Reduction in ASIR were reported while ASPR varies. Disease modifying anti-rheumatic drugs (DMARDs) remain the cornerstone of treatment.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

类风湿关节炎的流行病学综述：最新的文献和趋势。

类风湿性关节炎（RA）是一种主要影响关节的系统性慢性自身免疫性疾病，常伴有关节外表现。这篇综述提供了RA流行趋势和管理方面的最新进展。以2014 - 2024年类风湿关节炎为关键词，结合发病率、患病率、诊断、分类和管理，检索PubMed和EMBASE。重点是近5年发表的论文。在全球范围内，RA的年龄标准化患病率和发病率（ASPR和ASIR）以不同的数字增加。1990 - 2019年、2020年和2017年，ASPR分别增长了0.37%、14.1%和6.4%；从1980年到2019年，这一比例为9%。从1990年到2019年和2017年，ASIR分别增长了0.3%和8.2%；不同作者的残疾调整生命年（DALY）同期分别上升0.12%和下降0.36%。ASIR减少，而ASPR不同。疾病调节抗风湿药物（DMARDs）仍然是治疗的基石。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Best Practice & Research in Clinical Rheumatology 医学-风湿病学

CiteScore

9.40

自引率

0.00%

发文量

审稿时长

27 days

期刊介绍： Evidence-based updates of best clinical practice across the spectrum of musculoskeletal conditions. Best Practice & Research: Clinical Rheumatology keeps the clinician or trainee informed of the latest developments and current recommended practice in the rapidly advancing fields of musculoskeletal conditions and science. The series provides a continuous update of current clinical practice. It is a topical serial publication that covers the spectrum of musculoskeletal conditions in a 4-year cycle. Each topic-based issue contains around 200 pages of practical, evidence-based review articles, which integrate the results from the latest original research with current clinical practice and thinking to provide a continuous update. Each issue follows a problem-orientated approach that focuses on the key questions to be addressed, clearly defining what is known and not known. The review articles seek to address the clinical issues of diagnosis, treatment and patient management. Management is described in practical terms so that it can be applied to the individual patient. The serial is aimed at the physician in both practice and training.

期刊最新文献

T-cell engagers in rheumatology. CAR-T cell therapy for ANCA-associated vasculitis: Rationale, current evidence, and future directions. Renal involvement in systemic sclerosis. Malignancy and rheumatic diseases. Cellular therapies in systemic Sclerosis: immunopathogenesis-informed precision targeting with CAR-T and CAR-NK approaches.